Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
European Journal of Heart Failure|May 5, 2022
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosisAldostefano Porcari, Maddalena Rossi, Francesco Cappelli, et al.
Nature Medicine|May 1, 2007
MicroRNA-133 controls cardiac hypertrophyAlessandra Carè, Daniele Catalucci, Federica Felicetti, et al.
JACC. Cardiooncology|November 29, 2022
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic ValueAlberto Cipriani, Laura De Michieli, Aldostefano Porcari, et al.
The American Journal of Cardiology|June 1, 2015
Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic CardiomyopathyRaymond H Chan, Barry J Maron, Iacopo Olivotto, et al.
European Journal of Preventive Cardiology|November 1, 2024
Arrhythmic risk stratification in patients with left ventricular ring-like scarVanda Parisi, Maddalena Graziosi, Luis R Lopes, et al.
Circulation. Heart Failure|February 24, 2026
Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac AmyloidosisMattia Zampieri, Giulia Biagioni, Annamaria Del Franco, et al.
ESC Heart Failure|May 14, 2021
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide surveyGiacomo Tini, Francesco Cappelli, Elena Biagini, et al.
Journal of the American College of Cardiology|March 19, 2013
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathyBarry J Maron, Paolo Spirito, Michael J Ackerman, et al.
JACC. Clinical Electrophysiology|September 28, 2023
The Diagnostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular Cardiomyopathy: Novel ECG SignsLeonardo Calò, Cinzia Crescenzi, Annamaria Martino, et al.
Pageof 15